Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 1/20 | 0.38 |
| ▸ | CCKBR | P32239 | 4/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.37 |
| ▸ | CASP1 | P29466 | 1/20 | 0.36 |
| ▸ | RORC | P51449 | 3/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | NPY1R | P25929 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6177392 | 0.88 | CCKBR (0.39) | CCKBRMAPTCYP3A4TSHRLMNA | |
| SCHEMBL6177504 | 0.88 | CCKBR (0.39) | CCKBRMAPTCYP3A4TSHR | |
| SCHEMBL6176603 | 0.87 | CCKBR (0.39) | CCKBRMAPTCYP3A4TSHRLMNA | |
| SCHEMBL7959399 | 0.86 | CCKBR (0.38) | CCKBRMAPTCYP3A4TSHRLMNA | |
| SCHEMBL7959563 | 0.86 | HTT (0.37) | CCKBRMAPTCYP3A4TSHRNPY1R | |
| SCHEMBL6178660 | 0.85 | CCKBR (0.38) | CCKBRMAPTCYP3A4TSHRLMNA | |
| SCHEMBL7950861 | 0.85 | CCKBR (0.37) | CCKBRMAPTCYP3A4TSHRNPY1R | |
| SCHEMBL6176875 | 0.85 | CCKBR (0.39) | CCKBRMAPTCYP3A4TSHR | |
| SCHEMBL7961009 | 0.84 | CCKBR (0.38) | CCKBRMAPTCYP3A4TSHR | |
| SCHEMBL6176839 | 0.83 | HTT (0.41) | PDE4BLMNASCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6239131-B1 | WHICH HAVE GASTRIN AND/OR CCK-B (CHOLECYSTOKININ-B) RECEPTOR ANTAGONISM, USEFUL AS REMEDIES FOR GASTRIC ULCER AND GASTROINTESTINAL MOVEMENT DISORDER. | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 2001-05-29 | — | — | US | disclosed |